UNSPSC 51242203: Antipyrine/benzocaine/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OT900. This VA Drug Class (OT900) classifies this compound as belonging to the group OTIC AGENTS, OTHER.

UNSPSC 51242203 Antipyrine/benzocaine/phenylephrine, a Commodity code, covers generic multi-source pharmaceuticals and over-the-counter products that state and local government health and human services agencies procure for distribution across their facilities. State and local buyers under this code source through cooperative purchasing agreements and direct RFPs to establish blanket contracts with manufacturers and pharmaceutical suppliers. Issuing bodies include state departments of health and administration, participating state agencies, and affiliated local government facilities within multi-state purchasing alliances. The scope includes supply-chain compliance with FDA requirements, cGMP certification, DSCSA compliance, and delivery through established pharmaceutical wholesaler networks with EDI capability and chargebacks. Vendors must maintain minimum insurance coverage including $5,000,000 commercial general liability and provide products with expiration dates at least one year from manufacture and minimum six-month shelf life.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted the most recent significant opportunity under this code on January 20, 2026. MMCAP issued RFP S1070000015802 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products serving participating state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026. The procurement requires vendors to supply products through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) and emphasizes price competitiveness (75 percent of evaluation weight), with optional net-price or WAC-minus pricing structures. Awarded vendors become effective July 1, 2026, on a two-year term with discretionary extensions, subject to a 3 percent administrative fee and performance penalties ranging from $200 to $1,500 per violation.